SkinnyRX GLP-1

Product Details

SkinnyRx describes its program as providing prescription GLP-1 medication, clinician-guided care, digital tools, and ongoing patient support.

What Is SkinnyRX GLP-1?

SkinnyRX GLP-1 is a prescription weight-management service that connects eligible customers with independent licensed healthcare providers for clinical evaluation and, when appropriate, prescription treatment. The program currently features semaglutide options in several formats, including once-weekly injectable medication, once-daily sublingual medication, and once-daily tablets.

Semaglutide belongs to a class of medicines called GLP-1 receptor agonists. The medication works through GLP-1 receptors involved in appetite regulation, digestion, and insulin secretion. SkinnyRx combines prescription access with care-team support, progress tracking, nutrition guidance, movement, and sleep-focused resources.

Who May Consider SkinnyRX GLP-1?

Adults interested in clinician-guided weight management may consider SkinnyRx when they want prescription GLP-1 options together with personalised medical support. The online assessment collects health history, goals, preferences, and other information before a licensed provider determines whether prescription treatment is appropriate.

The program may also appeal to adults who prefer different medication formats, as SkinnyRx offers injectable and oral semaglutide options. Anyone experiencing ongoing or unexplained symptoms should obtain appropriate professional medical evaluation rather than relying solely on an online weight-management program.

How May SkinnyRX GLP-1 Support General Wellness?

Semaglutide acts on GLP-1 receptors and may support appetite regulation and feelings of fullness. It also influences gastric emptying and insulin secretion, mechanisms that are relevant to appetite and metabolic regulation.

SkinnyRx combines medication access with broader lifestyle support. Its program includes guidance related to nutrition, movement, sleep, medication use, progress tracking, and access to a care team.

SkinnyRx reports an average 27.1-pound weight reduction during the first six months and an average 14.9% body-weight reduction within one year among specified groups of self-reported members using GLP-1 injections alongside diet and exercise. These figures are company-reported member data rather than a guarantee of individual results.

Prescription Medication Information

SkinnyRX GLP-1 does not have a conventional Supplement Facts panel because it is a prescription medication service rather than a dietary supplement.

Semaglutide

The primary GLP-1 medication featured by SkinnyRx is semaglutide. The available formats include compounded injectable semaglutide, compounded sublingual semaglutide, and compounded semaglutide tablets.

Injectable Semaglutide

SkinnyRx lists compounded injectable semaglutide as a once-weekly prescription option, with microdosing available. The starting displayed price is $199 per month, with the exact prescription and dose determined through clinician evaluation.

Sublingual Semaglutide

The sublingual option is administered once daily by placing the medication under the tongue and allowing it to dissolve. SkinnyRx currently lists this option from $199 per month.

Semaglutide Tablets

SkinnyRx lists compounded semaglutide tablets as a once-daily oral option from $249 per month. The specific medication and dosing plan are determined following clinical assessment.

Active Ingredients

Semaglutide is the active medication associated with SkinnyRx’s semaglutide GLP-1 options. Individual compounded formulations may differ in inactive ingredients and concentration, so the dispensed prescription label should be followed.

Semaglutide

Semaglutide is a GLP-1 receptor agonist that mimics GLP-1 activity in the body. It is involved in appetite regulation, gastric emptying, and insulin secretion. The prescribed amount varies according to the individual treatment plan.

Other Ingredients and Allergens

Inactive ingredients, capsule or tablet materials, preservatives, flavouring agents, fillers, and declared allergens are not consistently disclosed on the public SkinnyRx pages reviewed.

For an individual prescription, consumers should consult the pharmacy-dispensed medication label or contact the dispensing pharmacy for complete inactive-ingredient and allergen information.

Potential Benefits

• Support appetite regulation through GLP-1 receptor activity, which may help manage hunger and support healthier eating patterns.
• Promote feelings of fullness by helping slow digestion and regulate food intake as part of a prescribed treatment plan.
• Support prescription weight management through a clinician-guided approach tailored to individual needs and treatment goals.
• Offer flexible semaglutide administration options based on the prescribed dosage, treatment plan, and healthcare provider’s recommendations.
• Provide ongoing support and monitoring through care-team access, progress tracking, and guidance on healthy lifestyle habits.

Important Limitations

• SkinnyRx GLP-1 is a prescription medication service rather than a dietary supplement.
• Exact medication strength and dosing are determined individually by a licensed prescribing provider.
• Individual experiences with prescription treatment can differ.

How to Use?

SkinnyRX GLP-1 comes in injectable and oral forms, depending on the medication prescribed.

• Injectable semaglutide is administered once weekly according to the prescription provided by the clinician.
• Sublingual semaglutide is administered once daily under the tongue.
• Tablet-based semaglutide is taken according to the individual prescription instructions.
• Follow the exact dose, timing, administration method, and storage instructions supplied with the dispensed medication.
• Do not change the prescribed dose or schedule without discussing it with the prescribing clinician.

SkinnyRx’s patient information states that dose changes and switching between oral and injectable forms should be determined with the provider.

Warnings and Precautions

• Prescription GLP-1 treatment should be used only after evaluation by an appropriate healthcare professional.
• People who are pregnant, planning pregnancy, or breastfeeding should discuss GLP-1 medication with their healthcare provider before use. SkinnyRx does not recommend GLP-1 medication during pregnancy or breastfeeding.
• Tell the prescribing provider about current prescription medicines, supplements, allergies, and relevant medical conditions.
• Discuss upcoming surgery or procedures with the healthcare team before using prescription GLP-1 medication.
• Seek prompt medical attention for severe or persistent symptoms, including severe abdominal pain, significant dehydration, difficulty breathing, facial or throat swelling, fainting, or vision changes.
• Keep prescription medication stored according to the dispensing pharmacy’s instructions.
• Keep medication away from children and anyone for whom it was not prescribed.
• Do not use medication if its packaging or safety seal appears damaged; contact the dispensing pharmacy for guidance.

Possible Side Effects and Interactions

Semaglutide can cause gastrointestinal effects such as nausea, constipation, diarrhea, vomiting, bloating, and abdominal discomfort, particularly during treatment initiation or dose increases. Fatigue and headache may also occur. Medication interactions depend on the individual’s prescription and health history, so people taking prescription medicines should discuss their complete medication list with a healthcare professional.

Manufacturing and Quality Information

SkinnyRx states that its GLP-1 medications are supplied through licensed U.S. pharmacies, with compounded products prepared in the U.S.A. This is intended to support controlled pharmacy-based dispensing and product handling.

For compounded semaglutide, SkinnyRx describes quality-control testing conducted by partner pharmacies through FDA- and DEA-compliant laboratories. Testing reportedly includes potency, sterility, pH, and endotoxin checks to help assess product quality and consistency.

Pros

• Multiple semaglutide administration formats are available.
• Clinician review is incorporated into the prescription process.
• Licensed U.S. providers are available through the program.
• Care-team support and progress-tracking tools are included.
• Free shipping is advertised for eligible medication orders.

Cons

• The exact medication, concentration, and dosage depend on clinical evaluation.
• Public pages do not provide a conventional Supplement Facts panel.
• Some inactive ingredients and individual pharmacy details are not publicly disclosed.

Pricing and Money-Back Guarantee

SkinnyRx currently offers several semaglutide formats with different monthly starting prices and flexible prescription options.

• Compounded Injectable Semaglutide: From $199/month; once-weekly administration; microdose option available.
• Compounded Sublingual Semaglutide: From $199/month; once-daily sublingual administration.
• Compounded Semaglutide Tablets: From $249/month; once-daily oral administration.
• Shipping: Free overnight shipping is advertised on the semaglutide product pages.
• Payment: Major credit cards and FSA/HSA cards are accepted.
• Subscription: Plans are offered as subscription services and can be cancelled according to the applicable program terms.

The current SkinnyRx injectable semaglutide page lists pricing from $199/month, while its oral tablet page lists pricing from $249/month.

Pricing and availability were checked on August 27, 2026 and may change on the official website.

Pharmacist Note

SkinnyRX GLP-1 is a prescription medication service, so the dispensed product should always be used according to its pharmacy label and prescriber’s instructions. Review your medications, supplements, allergies, and relevant health history with a healthcare professional before starting treatment.

Frequently Asked Questions

1. What type of product is SkinnyRX GLP-1?

SkinnyRX GLP-1 is a clinician-guided prescription weight-management program offering semaglutide in several administration formats.

2. How should SkinnyRX GLP-1 be taken?

Administration depends on the prescribed format, with injectable semaglutide generally used weekly and oral options generally used daily.

3. How long does one supply last?

The supply period depends on the prescribed medication, dose, formulation, and dispensing instructions provided with your individual prescription.

4. Can it be taken with prescription medication?

Discuss all current medicines and supplements with your prescribing clinician so potential interactions and appropriate treatment choices can be evaluated.

5. Is it suitable during pregnancy or breastfeeding?

SkinnyRx advises against GLP-1 medication during pregnancy or breastfeeding and recommends discussing treatment plans with a healthcare professional.

6. Does SkinnyRX GLP-1 require a prescription?

Yes. SkinnyRX GLP-1 is a prescription-based weight-management treatment that requires an evaluation by a qualified clinician before medication is prescribed.

Medical Disclaimer

This information is for general educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare professional before starting any new medication, supplement, or treatment. 

Sources and Product Review Information

• SkinnyRx Official Website
• SkinnyRx Compounded Injectable Semaglutide
• SkinnyRx Compounded Sublingual Semaglutide
• SkinnyRx Compounded Semaglutide Tablets
• FDA: Understanding the Risks of Compounded Drugs
• FDA: Compounding and the FDA – Questions and Answers
• Product information checked: August 27, 2026

Affiliate Disclosure: This page may contain affiliate links. If you make a purchase through one of these links, we may earn a commission at no additional cost to you. This does not influence the information presented above, which is based on publicly available product and label information.